Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Nephrology Summit 2025

Welcome Message

Dear Esteemed Participants,

On behalf of the Organizing Committee, it is our great honor and pleasure to welcome you all to the 14th International Conference on Nephrology and Kidney Diseases, scheduled for November 17–18, 2025, in the historic city of Rome, Italy.

This distinguished gathering brings together a global network of nephrologists, researchers, healthcare professionals, and industry leaders to explore the latest advances in the diagnosis, treatment, and management of kidney diseases. Through keynote presentations, scientific sessions, and interactive discussions, we aim to foster innovation and collaboration in the field of nephrology.

As kidney-related conditions continue to pose serious health challenges worldwide, this conference serves as a vital platform to exchange knowledge, present groundbreaking research, and build strategic partnerships that can improve patient care and outcomes.

We are confident that your participation will make this event a truly impactful and memorable experience. We encourage you to take full advantage of the scientific program and also enjoy the rich cultural and historical offerings of Rome.

Once again, welcome, and we look forward to an inspiring and productive conference with your valuable contributions.

Warm regards,
Organizing Committee
Nephrology Summit 2025
November 17–18, 2025 | Rome, Italy

About Conference


The 14th International Conference on Nephrology and Kidney Diseases will be held on November 17–18, 2025, in Rome, Italy, and promises to be a premier event uniting global experts in nephrology, renal research, and kidney care.

This two-day international gathering is designed to foster knowledge exchange, research collaboration, and innovation in all aspects of nephrology and kidney health. The conference will feature comprehensive scientific sessions, keynote addresses by distinguished experts, panel discussions, and interactive workshops covering a wide range of topics—from chronic kidney disease, dialysis, and kidney transplantation to hypertension, diabetic nephropathy, and advancements in renal diagnostics and therapeutics.

The event provides a dynamic platform for clinicians, researchers, academicians, renal nurses, healthcare practitioners, and industry professionals to present their findings, discuss challenges, explore future trends, and develop strategies to enhance patient outcomes in kidney care.

Set in the culturally rich city of Rome, the conference also offers an excellent opportunity to experience historical landmarks while engaging with peers in a stimulating academic environment.

We welcome your participation to help shape the future of nephrology and improve global kidney health.

Why to Attend

Attending the 29th European Nephrology Conference is a vital opportunity for professionals in nephrology, urology, and kidney research to stay informed and inspired by the latest developments in the field. This event offers a global platform to explore new technologies, evidence-based treatments, and forward-thinking approaches to kidney care.

Participants will have the chance to:

  • Learn from leading experts in nephrology, dialysis, and transplantation
  • Engage in hands-on workshops and interactive case-based sessions
  • Stay updated on recent research, innovations, and clinical breakthroughs
  • Earn CPD credits to support continued professional development
  • Network with peers, researchers, clinicians, and global thought leaders
  • Foster new collaborations, partnerships, and career opportunities

Target Audience

  • Nephrologists
  • Urologists
  • Kidney transplant surgeons
  • Renal care specialists
  • Dialysis technicians and nurses
  • Internal medicine physicians
  • Clinical researchers and scientists
  • Medical and healthcare students
  • Postgraduate trainees and fellows
  • Pharmaceutical and biotech professionals
  • Medical device manufacturers
  • Healthcare policymakers and administrators
  • Public health experts
  • Academic faculty and educators
  • Members of nephrology and urology societies
  • Pediatric nephrologists
  • Biomedical engineers working in renal technologies
  • Nutritionists and dietitians specializing in kidney care
  • Hospital and clinic decision-makers
  • Representatives from kidney health NGOs and foundations

Scientific Sessions

Track 01. Clinical Nephrology and Diagnostic Approaches

Clinical nephrology focuses on the accurate diagnosis and medical treatment of kidney-related disorders. It includes a comprehensive understanding of how to assess renal function using physical examination, laboratory evaluation, and imaging. Serum creatinine levels, blood urea nitrogen, glomerular filtration rate, and urinalysis remain essential tools in diagnosis. Advanced tests such as renal biopsy and imaging techniques like Doppler ultrasound, CT scan, or MRI help to determine structural abnormalities. Emphasis is placed on identifying early signs of kidney impairment and differentiating between acute and chronic renal disorders. Continuous monitoring and interpretation of clinical parameters aid in formulating an appropriate care plan and preventing disease progression.

Topics covered:
• Renal function tests and GFR measurement
• Urine microscopy and proteinuria evaluation
• Diagnostic imaging and renal biopsy

Track 02. Chronic Kidney Disease and Its Management

Chronic kidney disease is a progressive condition that may lead to end-stage renal disease if not properly managed. It involves a decline in kidney function over months or years, usually due to underlying conditions like diabetes or hypertension. Key components of management include blood pressure control, regulation of blood glucose, and the use of medications such as ACE inhibitors or ARBs to slow disease progression. Nutritional therapy, correction of anemia, and prevention of mineral bone disorders are vital. Early diagnosis and regular follow-up help to delay complications and avoid the need for dialysis or transplantation.

Topics covered:
• CKD staging and clinical guidelines
• Management of anemia and mineral imbalances
• Slowing disease progression with lifestyle changes

Track 03. Acute Kidney Injury: Causes and Interventions

Acute kidney injury is characterized by a sudden decrease in renal function, commonly caused by hypovolemia, nephrotoxins, or sepsis. Early identification and removal of the underlying cause are essential for recovery. Clinical signs include reduced urine output, fluid overload, and electrolyte imbalances. Diagnostic tools such as creatinine levels, urine output measurement, and fractional excretion of sodium help distinguish prerenal, intrinsic, and postrenal causes. Fluid management, avoidance of nephrotoxic drugs, and timely initiation of renal replacement therapy can improve outcomes. Collaboration between critical care and nephrology teams is often required.

Topics covered:
• Sepsis-induced AKI
• Nephrotoxicity and medication-induced AKI
• Dialysis indications in acute renal failure

Track 04. Innovations in Dialysis Technology

Advancements in dialysis have improved outcomes and quality of life for patients with kidney failure. Hemodialysis and peritoneal dialysis are the main modalities, with growing interest in home-based therapies. Innovations include high-flux membranes, wearable dialysis systems, and more efficient water purification techniques. Patient-centric approaches such as personalized dialysis dosing and dietary modifications enhance treatment tolerance. Complication management—such as preventing infections, managing vascular access, and reducing dialysis-related amyloidosis—is integral. The role of telehealth and remote monitoring has also expanded, making dialysis more accessible.

Topics covered:
• Comparison of hemodialysis and peritoneal dialysis
• Home-based dialysis and remote monitoring
• Advances in biocompatible membranes

Track 05. Kidney Transplantation and Long-Term Care

Kidney transplantation offers improved survival and quality of life compared to long-term dialysis. Donor matching, pre-transplant evaluation, and perioperative care are essential for success. Post-transplant management focuses on preventing rejection through immunosuppressive therapy, monitoring for infections, and managing cardiovascular risk. Emerging strategies include desensitization in highly sensitized patients and non-invasive graft surveillance techniques. Long-term care includes regular kidney function testing and patient education to enhance adherence to medication regimens and lifestyle recommendations.

Topics covered:
• Deceased vs. living donor outcomes
• Immunosuppression and graft rejection
• Post-transplant infections and cancer risks

Track 06. Pediatric Nephrology and Congenital Disorders

Kidney diseases in children present unique challenges, often involving congenital anomalies or inherited conditions. Common pediatric renal disorders include vesicoureteral reflux, posterior urethral valves, nephrotic syndrome, and hemolytic uremic syndrome. Early diagnosis is critical to prevent long-term damage and growth impairment. Management strategies often involve nutritional support, immunosuppressive therapies, and careful fluid-electrolyte balance. In severe cases, dialysis or kidney transplantation is considered, with protocols adapted for pediatric physiology. Advancements in genetic testing and fetal ultrasonography have improved the detection of congenital anomalies of the kidney and urinary tract. Collaborative care involving pediatric nephrologists, urologists, dietitians, and social workers plays a crucial role in achieving optimal outcomes.

Topics covered:
• Congenital anomalies of the kidney and urinary tract (CAKUT)
• Pediatric dialysis and transplantation
• Genetic testing and counseling in pediatric nephrology

Track 07. Glomerular Diseases and Immune Mechanisms

Glomerular diseases represent a significant category of kidney pathology, often mediated by immune mechanisms. Conditions such as minimal change disease, membranous nephropathy, focal segmental glomerulosclerosis, and rapidly progressive glomerulonephritis are major contributors to nephrotic and nephritic syndromes. Diagnosis typically requires clinical assessment, serological markers, and histological confirmation via renal biopsy. Immunosuppressive therapies, including corticosteroids, calcineurin inhibitors, and biologics such as rituximab, have transformed treatment outcomes. Understanding the role of autoantibodies, complement activation, and cytokine release has opened pathways for targeted therapy. Ongoing research aims to refine classification systems based on molecular profiling rather than solely histopathology.

Topics covered:
• Nephrotic and nephritic syndrome
• Renal biopsy interpretation and classification
• Immunotherapy and targeted treatment

Track 08. Hypertension and Kidney Interactions

Hypertension is closely linked with kidney disease, both as a cause and a consequence. Renal parenchymal and renovascular hypertension result from damage to renal structures, while chronic high blood pressure accelerates glomerulosclerosis and tubulointerstitial fibrosis. Effective blood pressure control is central to preserving renal function. Therapeutic approaches include renin-angiotensin system inhibitors, calcium channel blockers, and diuretics, with individualized regimens for resistant hypertension. Ambulatory blood pressure monitoring has gained prominence in assessing true control and nocturnal dipping patterns. Lifestyle interventions such as salt restriction and exercise are emphasized alongside pharmacological therapy to optimize renal outcomes.

Topics covered:
• Pathophysiology of hypertension-induced kidney damage
• Resistant hypertension management
• Ambulatory blood pressure monitoring in CKD

Track 09. Diabetic Kidney Disease and Metabolic Syndromes

Diabetic kidney disease is a leading cause of chronic kidney disease and end-stage renal disease worldwide. Hyperglycemia triggers glomerular hyperfiltration, mesangial expansion, and ultimately glomerulosclerosis. Microalbuminuria is an early marker, progressing to proteinuria and declining glomerular filtration rate. Management focuses on optimal glycemic control, blood pressure regulation, and the use of agents like sodium-glucose cotransporter-2 inhibitors and angiotensin receptor blockers, which offer renal protection. Recent guidelines recommend individualizing therapy based on cardiovascular and renal risk profiles. Nutritional management and regular screening are essential to delay progression. Emphasis is also placed on identifying high-risk individuals with metabolic syndrome features for early intervention.

Topics covered:
• Early diagnosis and biomarkers
• Role of SGLT2 inhibitors and GLP-1 receptor agonists
• Risk stratification and lifestyle modification

Track 10. Autoimmune Renal Diseases and Vasculitis

Autoimmune disorders affecting the kidneys often involve complex systemic inflammation and immune dysregulation. Conditions such as lupus nephritis, anti-glomerular basement membrane disease, IgA vasculitis (Henoch-Schönlein purpura), and ANCA-associated vasculitis result in varying degrees of glomerular and tubular injury. Diagnosis includes autoantibody profiling, complement levels, and biopsy to assess disease activity and chronicity. Treatment generally involves corticosteroids, cyclophosphamide, rituximab, or mycophenolate mofetil. Disease monitoring relies on clinical response, proteinuria reduction, and renal function stabilization. Recent advances in biologic agents have improved outcomes while reducing adverse effects, and clinical trials continue to refine treatment protocols.

Topics covered:
• Systemic lupus erythematosus and lupus nephritis
• ANCA-associated vasculitis and renal involvement
• Immunosuppressive protocols and biologic therapies

Track 11. Imaging Modalities in Kidney Disease Diagnosis

Imaging plays a central role in the evaluation and management of kidney disorders. Non-invasive techniques such as renal ultrasound are often the first step in assessing kidney size, structure, and the presence of hydronephrosis or cysts. Doppler ultrasound helps evaluate renal blood flow and can detect renovascular abnormalities. Computed tomography and magnetic resonance imaging provide high-resolution details for complex cases, including masses, obstructions, or congenital anomalies. Nuclear medicine scans like DMSA and MAG3 are particularly useful for assessing renal scarring and differential renal function. Imaging also guides percutaneous procedures such as biopsies and drainage. The use of contrast agents in imaging requires caution in patients with reduced renal function due to the risk of contrast-induced nephropathy.

Topics covered:
• Role of renal ultrasound and Doppler studies
• CT and MRI applications in nephrology
• Nuclear scans for renal perfusion and function

Track 12. Genetic and Inherited Kidney Disorders

Genetic factors contribute significantly to the development of several kidney diseases. Autosomal dominant polycystic kidney disease is the most common inherited kidney disorder and is characterized by progressive cyst formation, leading to kidney enlargement and failure. Alport syndrome, caused by mutations in type IV collagen, leads to progressive glomerular disease with hearing loss and ocular abnormalities. Advances in molecular genetics and next-generation sequencing have enabled early diagnosis, especially in children with a family history of kidney disease. Genetic counseling and risk assessment are important components of care. Research into gene therapy and molecular-targeted treatments offers hope for the future management of hereditary renal conditions.

Topics covered:
• Polycystic kidney disease and its management
• Alport syndrome and collagen gene mutations
• Genetic counseling in inherited nephropathies

Track 13. Renal Nutrition and Dietary Management

Nutritional therapy is a cornerstone in managing patients with kidney disease. Proper dietary intervention helps slow disease progression, manage symptoms, and improve quality of life. Protein intake must be carefully adjusted based on the stage of kidney disease—restricted in non-dialysis patients to minimize uremic toxins, and increased during dialysis to compensate for protein losses. Sodium, potassium, phosphorus, and fluid intake require regulation to avoid complications such as hypertension, hyperkalemia, and mineral bone disorders. Nutritional education and individualized plans from renal dietitians help ensure patient adherence and prevent malnutrition. Specialized supplements and enteral nutrition may be necessary in advanced cases.

Topics covered:
• Protein and electrolyte balance in CKD
• Nutritional strategies for dialysis patients
• Preventing malnutrition in renal disease

Track 14. Urological Disorders with Renal Impact

Urological abnormalities often lead to or exacerbate kidney disease. Obstructive uropathy from conditions like kidney stones, ureteral strictures, benign prostatic hyperplasia, or tumors can cause hydronephrosis and eventual renal impairment. Recurrent urinary tract infections, vesicoureteral reflux, and neurogenic bladder also pose risks to renal function. Diagnostic tools such as voiding cystourethrogram, urodynamic studies, and cystoscopy are important for comprehensive evaluation. Interventional strategies include stenting, lithotripsy, and reconstructive surgery. Timely identification and management of urological issues are essential in preserving renal function and preventing irreversible damage.

Topics covered:
• Obstructive uropathy and hydronephrosis
• Urinary tract infections and reflux nephropathy
• Urological interventions in renal preservation

Track 15. Technological Innovations in Nephrology

Advancements in medical technology are reshaping nephrology care. Artificial kidneys and bioengineered tissues are being explored as alternatives to traditional dialysis and transplantation. Wearable dialysis devices aim to offer patients mobility and flexibility, reducing the burden of in-center treatments. Nanotechnology is improving drug delivery systems and enabling earlier disease detection through nanosensors. Digital health tools such as mobile applications, telemedicine, and wearable monitors help in remote patient management and adherence tracking. Data-driven models using artificial intelligence are now being developed to predict disease progression, personalize treatment plans, and detect complications in real time.

Topics covered:
• Wearable and artificial kidney devices
• Nanomedicine in kidney disease management
• Remote monitoring and digital health tools

Track 16. Inflammation, Oxidative Stress, and Renal Fibrosis

Chronic inflammation and oxidative stress are central to the progression of kidney diseases. Pro-inflammatory cytokines and reactive oxygen species contribute to cellular injury, glomerulosclerosis, and tubular interstitial fibrosis. Persistent inflammation leads to irreversible changes in kidney structure, ultimately reducing functional nephron mass. Renal fibrosis is the final common pathway in both acute and chronic kidney conditions. Therapeutic strategies target key molecular pathways such as transforming growth factor-beta (TGF-β), nuclear factor kappa B (NF-κB), and the renin-angiotensin system. Antioxidants, anti-inflammatory agents, and antifibrotic drugs are under investigation to halt or reverse this progression. A better understanding of these mechanisms opens the door to personalized medicine and more effective renal protection strategies.

Topics covered:
• Molecular mechanisms of renal inflammation
• Fibrosis and its impact on kidney function
• Antioxidants and anti-inflammatory therapies

Track 17. Post-Infectious and Acute Glomerular Syndromes

Infections can trigger glomerular inflammation and immune complex deposition, resulting in post-infectious glomerulonephritis. Streptococcal infections are classic causes, especially in children, though other pathogens such as hepatitis B and C, HIV, and Staphylococcus aureus may also contribute. Clinical presentation includes hematuria, proteinuria, edema, and hypertension. Diagnosis relies on serology, complement levels, and renal biopsy. Management is generally supportive but may require immunosuppressive therapy in severe cases. Early treatment of the underlying infection, along with monitoring for long-term renal sequelae, is crucial. Recognizing these syndromes promptly can prevent progression to chronic kidney disease.

Topics covered:
• Streptococcal and Staphylococcal-associated nephritis
• Complement system in glomerular injury
• Treatment strategies for infection-triggered nephropathy

Track 18. Cardio-Renal Syndrome and Multisystem Impact

The heart and kidneys are intricately linked, and dysfunction in one organ can lead to deterioration in the other—a phenomenon known as cardio-renal syndrome. This complex interplay involves hemodynamic changes, neurohormonal activation, inflammation, and oxidative stress. Five types of cardio-renal syndrome are recognized, based on the initiating organ and whether the dysfunction is acute or chronic. Management requires careful balancing of volume status, blood pressure, and use of medications like diuretics, angiotensin-converting enzyme inhibitors, and beta-blockers. Collaboration between cardiologists and nephrologists ensures coordinated care, especially in heart failure patients with worsening kidney function. Personalized therapies targeting both organs simultaneously are the future of integrated cardio-renal care.

Topics covered:
• Types and classification of cardio-renal syndrome
• Fluid and drug management challenges
• Collaborative heart-kidney treatment strategies

Track 19. Renal Disease in the Elderly Population

Kidney function naturally declines with age, but elderly individuals are also more susceptible to both acute and chronic renal conditions due to comorbidities like hypertension, diabetes, and cardiovascular disease. Age-related changes in kidney structure and perfusion make diagnosis and management more complex. Polypharmacy increases the risk of nephrotoxicity and drug interactions. Treatment goals must consider life expectancy, frailty, and patient preferences. Conservative management may be more appropriate than dialysis in some cases, with a focus on symptom control and maintaining quality of life. Geriatric nephrology emphasizes holistic care, careful medication adjustment, and shared decision-making with patients and families.

Topics covered:
• Physiological renal aging and comorbidities
• Dialysis versus conservative care in older adults
• Polypharmacy and dose adjustments in the elderly

Track 20. Artificial Intelligence and Predictive Analytics in Kidney Care

Artificial intelligence and predictive analytics are transforming nephrology by enhancing diagnostic accuracy, personalizing treatment, and improving patient outcomes. Machine learning algorithms can analyze large datasets to detect early signs of kidney disease, predict dialysis needs, and identify patients at risk for complications like hyperkalemia or fluid overload. Clinical decision support systems guide medication adjustments and highlight potential drug interactions in complex patients. Predictive models also aid in transplant outcomes, graft survival, and hospitalization risk. Integration of AI tools into electronic health records is becoming increasingly common, empowering clinicians to make informed, data-driven decisions. Ethical considerations, data privacy, and validation remain important challenges in the widespread adoption of AI in kidney care.

Topics covered:
• AI in early detection of kidney dysfunction
• Predictive modeling for dialysis and transplant planning
• Clinical decision support tools in nephrology

Market Analysis Report

The global burden of kidney diseases is rising at an alarming rate, with an estimated 850 million people affected by chronic kidney disease (CKD) worldwide. Factors such as aging populations, increased incidence of diabetes and hypertension, and lifestyle-related disorders are driving the surge in kidney-related conditions. These trends have significantly amplified the demand for advanced diagnostics, dialysis services, and therapeutic interventions, placing nephrology at the forefront of global healthcare priorities.

According to market research, the global nephrology and urology devices market was valued at USD 19.4 billion in 2023 and is projected to reach USD 29.6 billion by 2030, growing at a CAGR of 6.2%. The renal dialysis market, a major segment within nephrology, is expected to expand from USD 97.7 billion in 2023 to USD 136.2 billion by 2030. Key growth drivers include technological innovations in dialysis machines, wearable kidney devices, tele-nephrology, and personalized treatment approaches. Regions such as North America and Europe lead the market, while Asia-Pacific shows the fastest growth due to its large patient base and improving healthcare infrastructure.

As research and innovation continue to advance, the nephrology landscape is rapidly evolving. Future trends point toward increased integration of artificial intelligence, regenerative medicine, and remote patient monitoring for early detection and improved disease management. With strong support from public health policies, academic research, and industry collaboration, the nephrology and kidney care market is set to grow significantly in the coming years, offering promising opportunities for medical professionals, researchers, and healthcare organizations globally.

Associations and Societies related to Nephrology:

  • International Society of Nephrology (ISN)
  • American Society of Nephrology (ASN)
  • European Renal Association (ERA)
  • National Kidney Foundation (NKF)
  • Asian Pacific Society of Nephrology (APSN)
  • International Federation of Kidney Foundations (IFKF)
  • International Pediatric Nephrology Association (IPNA)
  • Latin American Society of Nephrology and Hypertension (SLANH)
  • Canadian Society of Nephrology (CSN)
  • Australian and New Zealand Society of Nephrology (ANZSN)
  • Indian Society of Nephrology (ISN India)
  • Japanese Society of Nephrology (JSN)
  • Chinese Society of Nephrology (CSN China)
  • African Association of Nephrology (AFRAN)
  • British Renal Society (BRS)
  • Renal Association (UK)
  • German Society of Nephrology (DGfN)
  • Italian Society of Nephrology (SIN)
  • French Society of Nephrology, Dialysis and Transplantation (SFNDT)
  • Saudi Society of Nephrology and Transplantation (SSN&T)
  • Korean Society of Nephrology (KSN)
  • Bangladesh Renal Association (BRA)
  • Pakistan Society of Nephrology (PSN)
  • Egyptian Society of Nephrology and Transplantation (ESNT)

Participation Benefits

  • Participants will receive a certificate of participation

  • Speaker profiles will be added to the conference website

  • Networking with global nephrology professionals

  • International Networking Opportunities

  • Two days of complimentary breakfast, lunch, and refreshments

  • Young researcher and best poster awards

  • Abstracts published in a journal with DOI

  • Organization/clinic logo featured on website and in proceedings book

Past Conference Report

Nephrology Summit 2023

The 13th International Conference on Nephrology and Kidney Diseases, held on May 16–17, 2023, in Singapore City, was a resounding success, bringing together a distinguished assembly of nephrologists, urologists, researchers, academicians, clinicians, and healthcare professionals from across the globe. The conference served as a vibrant platform for sharing the latest advancements, clinical practices, and research developments in the field of nephrology and kidney care.

With a strong scientific agenda featuring keynote lectures, oral and poster presentations, panel discussions, and networking sessions, the conference provided a dynamic and collaborative environment. Esteemed speakers addressed a wide range of topics including chronic kidney disease, dialysis innovations, renal transplantation, glomerular disorders, and personalized nephrology.

The organizing committee extends sincere gratitude to all participants, speakers, sponsors, and collaborators for their valuable contributions that made the event impactful. The success of the 2023 edition has set a strong foundation for upcoming editions, continuing the mission to advance kidney health through global collaboration and innovation.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 17-18, 2025

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Nephrology & Therapeutics Nephrology & Renal Therapy Journal of Nephrology and Urology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Acute Kidney Injury
  • Alport Syndrome
  • Artificial Kidney Development
  • Bartter Syndrome
  • Biomarkers In Kidney Disease
  • Bladder Dysfunction
  • Bone And Mineral Disorders In CKD
  • Cardio-Renal Syndrome
  • Chronic Kidney Disease
  • CKD Screening And Prevention
  • Clinical Trials In Nephrology
  • Continuous Renal Replacement Therapy
  • Diabetic Nephropathy
  • Dialysis Complications
  • Electrolyte Imbalances
  • End-Stage Renal Disease
  • Fluid Management In CKD
  • Focal Segmental Glomerulosclerosis
  • Genetics Of Kidney Diseases
  • Geriatric Nephrology
  • Gitelman Syndrome
  • Global Kidney Health Initiatives
  • Glomerulonephritis
  • Goodpasture Syndrome
  • Health Economics In Nephrology
  • Hemodialysis
  • Hemolytic Uremic Syndrome
  • Home Dialysis
  • Hyperkalemia
  • Hypertensive Nephropathy
  • Hyponatremia
  • IgA Nephropathy
  • Infectious Complications In Dialysis
  • Innovations In Dialysis Technology
  • Interstitial Nephritis
  • Kidney Biopsy Interpretation
  • Kidney Cancer
  • Kidney Transplantation
  • Living Donor Kidney Transplant
  • Lupus Nephritis
  • Membranous Nephropathy
  • Metabolic Acidosis
  • Minimal Change Disease
  • Nephrolithiasis
  • Nephrology Nursing
  • Nephrotic Syndrome
  • Nephrotoxic Medications
  • Nocturnal Dialysis
  • Obstructive Uropathy
  • Organ Rejection And Immunosuppression
  • Patient-Centered Kidney Care
  • Pediatric Kidney Transplantation
  • Pediatric Nephrology
  • Peritoneal Dialysis
  • Pharmacology In Nephrology
  • Polycystic Kidney Disease
  • Precision Medicine In Nephrology
  • Pregnancy And Kidney Disease
  • Renal Anemia Management
  • Renal Cell Carcinoma
  • Renal Imaging And Ultrasound
  • Renal Nutrition
  • Renal Pathology
  • Renal Tubular Acidosis
  • Renovascular Hypertension
  • Tele-nephrology
  • Urinary Tract Infections
  • Urological Disorders
  • Vascular Access For Hemodialysis
  • Vesicoureteral Reflux
  • Wearable Dialysis Devices
  • Wilms Tumor